compounding semaglutide fda news Hims & Hers stock falls 25% as curtails compounded GLP-1s FDA says 'no clinical need'

Gastrointestinal Effects Nausea represents the most common side effect, reported by approximately 25-30% of users at maintenance doses

Policymakers must balance the potential for long-term cost savings against immediate budget constraints

Drugmakers, regulators, insurers, and healthcare providers are all preparing for the possibility that generic GLP-1 drugs could expand treatment access while also changing prescribing patterns and long-term care strategies

Metabolic Effects of GLP-1RA Administration The administration of GLP-1RAs, like liraglutide, exenatide, semaglutide, and lixisenatide, has multiple metabolic effects, such as glucose-dependent insulin secretion, slower gastric emptying, increased natriuresis and diuresis, increased pancreatic -cell mass, regulation of lipid metabolism, and decreased fat deposition, and has attracted considerable interest in recent years for its role in improving glycemic control and aiding weight loss in T2DM patients [48]

Most analysts have told the same story for a year

An active Eden Membership is required ($39 for the first month, auto-renews at $99/month thereafter)